Your Article Summary
PhRMA Statement Supporting House Vote on Biosimilars
PhRMA, 08/03/09
Pharmaceutical Research and Manufacturers of America President and CEO Billy Tauzin issued the following statement regarding the U.S. House Committee on Energy and Commerce's endorsement of reasonable data protection: "PhRMA, along with research universities, patients and healthcare providers, support the development of a responsible, abbreviated approval pathway for biosimilars.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/08/09
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Amgen, 12/08/09
Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
b3c newswire, 12/07/09
Article Search
Sponsor


See Latest Articles


